Literature DB >> 20587998

Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus.

Scott D Kobayashi1, Kevin R Braughton, Amy M Palazzolo-Ballance, Adam D Kennedy, Elizabeth Sampaio, Ervand Kristosturyan, Adeline R Whitney, Daniel E Sturdevant, David W Dorward, Steven M Holland, Barry N Kreiswirth, James M Musser, Frank R DeLeo.   

Abstract

Mechanisms underlying the enhanced virulence phenotype of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are incompletely defined, but presumably include evasion of killing by human polymorphonuclear leukocytes (PMNs or neutrophils). To better understand this phenomenon, we investigated the basis of rapid PMN lysis after phagocytosis of USA300, a prominent CA-MRSA strain. Survival of USA300 clinical isolates after phagocytosis ultimately resulted in neutrophil lysis. PMNs containing ingested USA300 underwent morphological changes consistent with apoptosis, but lysed rapidly thereafter (within 6 h), whereas cells undergoing FAS-mediated apoptosis or phagocytosis-induced cell death remained intact. Phagosome membranes remained intact until the point of PMN destruction, suggesting lysis was not caused by escape of S. aureus from phagosomes or the cytolytic action of pore-forming toxins. Microarray analysis of the PMN transcriptome after phagocytosis of representative community-associated S. aureus and healthcare-associated MRSA strains revealed changes unique to community-associated S. aureus strains, such as upregulation of transcripts involved in regulation of calcium homeostasis. Collectively, the data suggest that neutrophil destruction after phagocytosis of USA300 is in part a form of programmed necrosis rather than direct lysis by S. aureus pore-forming toxins. We propose that the ability of CA-MRSA strains to induce programmed necrosis of neutrophils is a component of enhanced virulence.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587998      PMCID: PMC3219502          DOI: 10.1159/000317134

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  40 in total

Review 1.  Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

Authors:  Jovanka M Voyich; Michael Otto; Barun Mathema; Kevin R Braughton; Adeline R Whitney; Diane Welty; R Daniel Long; David W Dorward; Donald J Gardner; Gérard Lina; Barry N Kreiswirth; Frank R DeLeo
Journal:  J Infect Dis       Date:  2006-11-02       Impact factor: 5.226

Review 3.  Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Steven R Gill; Richard F Chang; Tiffany HaiVan Phan; Jason H Chen; Matthew G Davidson; Felice Lin; Jessica Lin; Heather A Carleton; Emmanuel F Mongodin; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

4.  Composition of staphylococcal bi-component toxins determines pathophysiological reactions.

Authors:  B König; G Prévost; W König
Journal:  J Med Microbiol       Date:  1997-06       Impact factor: 2.472

5.  Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils.

Authors:  Jovanka M Voyich; Kevin R Braughton; Daniel E Sturdevant; Adeline R Whitney; Battouli Saïd-Salim; Stephen F Porcella; R Daniel Long; David W Dorward; Donald J Gardner; Barry N Kreiswirth; James M Musser; Frank R DeLeo
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

6.  Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain.

Authors:  Steven R Gill; Derrick E Fouts; Gordon L Archer; Emmanuel F Mongodin; Robert T Deboy; Jacques Ravel; Ian T Paulsen; James F Kolonay; Lauren Brinkac; Mauren Beanan; Robert J Dodson; Sean C Daugherty; Ramana Madupu; Samuel V Angiuoli; A Scott Durkin; Daniel H Haft; Jessica Vamathevan; Hoda Khouri; Terry Utterback; Chris Lee; George Dimitrov; Lingxia Jiang; Haiying Qin; Jan Weidman; Kevin Tran; Kathy Kang; Ioana R Hance; Karen E Nelson; Claire M Fraser
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

7.  Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Cell Microbiol       Date:  2006-07-04       Impact factor: 3.715

Review 8.  Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response.

Authors:  Nele Festjens; Tom Vanden Berghe; Peter Vandenabeele
Journal:  Biochim Biophys Acta       Date:  2006-07-08

9.  Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1.

Authors:  M F Rizkallah; A Tolaymat; J S Martinez; P M Schlievert; E M Ayoub
Journal:  Am J Dis Child       Date:  1989-07

10.  The survival of staphylococci within human leukocytes.

Authors:  D E ROGERS; R TOMPSETT
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

View more
  78 in total

Review 1.  How methicillin-resistant Staphylococcus aureus evade neutrophil killing.

Authors:  Mallary Greenlee-Wacker; Frank R DeLeo; William M Nauseef
Journal:  Curr Opin Hematol       Date:  2015-01       Impact factor: 3.284

Review 2.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

3.  Statins enhance formation of phagocyte extracellular traps.

Authors:  Ohn A Chow; Maren von Köckritz-Blickwede; A Taylor Bright; Mary E Hensler; Annelies S Zinkernagel; Anna L Cogen; Richard L Gallo; Marc Monestier; Yanming Wang; Christopher K Glass; Victor Nizet
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

Review 4.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

5.  Staphylococcus aureus Inhibits Neutrophil-derived IL-8 to Promote Cell Death.

Authors:  Oliwia W Zurek; Kyler B Pallister; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2015-02-26       Impact factor: 5.226

6.  Leukocidins and the Nuclease Nuc Prevent Neutrophil-Mediated Killing of Staphylococcus aureus Biofilms.

Authors:  Mohini Bhattacharya; Evelien T M Berends; Xuhui Zheng; Preston J Hill; Rita Chan; Victor J Torres; Daniel J Wozniak
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

7.  The impact of α-toxin on host cell plasma membrane permeability and cytokine expression during human blood infection by CA-MRSA USA300.

Authors:  Tyler K Nygaard; Kyler B Pallister; Oliwia W Zurek; Jovanka M Voyich
Journal:  J Leukoc Biol       Date:  2013-09-11       Impact factor: 4.962

8.  Phosphatidylinositol-specific phospholipase C contributes to survival of Staphylococcus aureus USA300 in human blood and neutrophils.

Authors:  Mark J White; Jeffrey M Boyd; Alexander R Horswill; William M Nauseef
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

Review 9.  Mcl-1 is vital for neutrophil survival.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

10.  Differential antibacterial control by neutrophil subsets.

Authors:  Pieter H C Leliefeld; Janesh Pillay; Nienke Vrisekoop; Marjolein Heeres; Tamar Tak; Matthijs Kox; Suzan H M Rooijakkers; Taco W Kuijpers; Peter Pickkers; Luke P H Leenen; Leo Koenderman
Journal:  Blood Adv       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.